Extracts of Magnolia Species-Induced Prevention of Diabetic Complications: A Brief Review
| Autor: | Yang Zheng, Xuezhong Zhao, Lu Cai, Kyoung Tae Kim, Ki Soo Kim, Ling Gao, Zhiguo Zhang, Wanqing Sun, Fengsheng Li |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2016 |
| Předmět: |
0301 basic medicine
MAGNOLIA BARK Review medicine.disease_cause complex mixtures Catalysis Inorganic Chemistry Diabetic nephropathy lcsh:Chemistry 03 medical and health sciences 0302 clinical medicine Diabetes mellitus Hyperlipidemia Diabetes Mellitus medicine diabetic complications Humans oxidative stress Diabetic Nephropathies Medicine Chinese Traditional Physical and Theoretical Chemistry Molecular Biology lcsh:QH301-705.5 Spectroscopy Traditional medicine Plant Extracts business.industry Organic Chemistry General Medicine Chinese society medicine.disease Obesity Computer Science Applications 030104 developmental biology lcsh:Biology (General) lcsh:QD1-999 Cardiovascular Diseases Magnolia Hyperglycemia 030220 oncology & carcinogenesis business Oxidative stress |
| Zdroj: | International Journal of Molecular Sciences, Vol 17, Iss 10, p 1629 (2016) International Journal of Molecular Sciences |
| ISSN: | 1422-0067 |
| Popis: | Diabetic complications are the major cause of mortality for the patients with diabetes. Oxidative stress and inflammation have been recognized as important contributors for the development of many diabetic complications, such as diabetic nephropathy, hepatopathy, cardiomyopathy, and other cardiovascular diseases. Several studies have established the anti-inflammatory and oxidative roles of bioactive constituents in Magnolia bark, which has been widely used in the traditional herbal medicines in Chinese society. These findings have attracted various scientists to investigate the effect of bioactive constituents in Magnolia bark on diabetic complications. The aim of this review is to present a systematic overview of bioactive constituents in Magnolia bark that induce the prevention of obesity, hyperglycemia, hyperlipidemia, and diabetic complications, including cardiovascular, liver, and kidney. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|